Skip to main content

Endocrinopathies and Other Biochemical Abnormalities in Pituitary Apoplexy

  • Chapter
  • First Online:
Pituitary Apoplexy

Abstract

Endocrinopathy and other biochemical abnormalities may be the result of the underlying macroadenoma or due to the pituitary apoplexy itself. Failure to recognise and treat any of these abnormalities may lead to increased morbidity and mortality in patients with pituitary apoplexy. The majority of patients will present with at least one anterior pituitary hormone deficiency, with ACTH the most common. Diabetes insipidus is seen in up to 27 % of cases and may be a presenting feature of pituitary apoplexy or only manifest postoperatively. Hyponatraemia is seen in up to 40 % of patients, may be an early or late event and may be related to surgery. SIADH is very uncommon.

The emergency management in an individual in whom pituitary apoplexy is suspected includes drawing blood for electrolyte and hormonal assessment. Careful attention to fluid management is necessary. Hydrocortisone replacement, even prior to getting the results of assays, is mandatory and helps in reducing haemodynamic instability.

There remains controversy around the timing of surgery and even if surgery is necessary in some cases. A reasonable approach is to perform early surgery, within the first week of symptoms, in patients with severely threatened vision, including blindness, or in whom there is a diminished level of consciousness. The advantage of delaying surgery in the rest of the patients is that it allows for a complete endocrine assessment and correction of fluid and electrolyte disturbances, permitting safer surgery and a better outcome.

The postoperative management revolves around careful monitoring of the patients electrolyte and fluid balance, remaining vigilant for the development of diabetes insipidus and treating it if necessary. The hydrocortisone dose is usually tapered to a maintenance dose, and at a later stage the cortisol requirement can be assessed. Thyroid hormone may also need to be replaced but only after 48 h of hydrocortisone.

Although the majority of patients will require anterior pituitary hormone replacement, there may be recovery of hormonal function in some patients. Permanent diabetes insipidus is present only in about 8 % of cases. All patients require an annual review of their endocrine status

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACTH:

Adrenocorticotrophic hormone

ADH:

Antidiuretic hormone

DI:

Diabetes insipidus

FSH:

Follicle-stimulating hormone

IGF-1:

Insulin-like growth factor-1

LH:

Luteinising hormone

SIADH:

Syndrome of inappropriate diuretic hormone

T4:

Thyroid hormone-4

UK:

United Kingdom

References

  • Agrawal D, Mahapatra A. Pituitary apoplexy and inappropriate ADH secretion. J Clin Neurosci. 2003;10:260–1.

    Article  PubMed  Google Scholar 

  • Arafah BM, Harrington JF, Madhoun ZT, Selman WR. Improvement of pituitary function after surgical decompression for pituitary apoplexy. J Clin Endocrinol Metab. 1990;71:323–8.

    Article  PubMed  CAS  Google Scholar 

  • Arlt W. Adrenal insufficiency. Clin Med. 2008;8:211–5.

    Article  PubMed  Google Scholar 

  • Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Acute management of pituitary apoplexy – surgery or conservative management? Clin Endocrinol (Oxf). 2004;61:747–52.

    Article  Google Scholar 

  • Bills DC, Meyer FB, Laws Jr ER, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993;33:602–9.

    Article  PubMed  CAS  Google Scholar 

  • Biousse V, Newman N, Oyesiku N. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001;71:542–5.

    Article  PubMed  CAS  Google Scholar 

  • Bonicki W, Kasperlik-ZaÅ‚uska A, Koszewski W, ZgliczyÅ„ski W, WisÅ‚awski J. Pituitary apoplexy: endocrine surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien). 1993;120:118–22.

    Article  CAS  Google Scholar 

  • Cardoso E, Peterson E. Pituitary apoplexy: a review. Neurosurgery. 1984;14:363–73.

    Article  PubMed  CAS  Google Scholar 

  • Chanson P, Lepeintre J, Ducreux D. Management of pituitary apoplexy. Expert Opin Pharmacother. 2004;5:1287–98.

    Article  PubMed  CAS  Google Scholar 

  • Choudhry OJ, Choudhry AJ, Nunez EA, Eloy JA, Couldwell WT, Ciric IS, Liu JK. Pituitary tumor apoplexy in patients with Cushing’s disease: endocrinologic and visual outcomes after transsphenoidal surgery. Pituitary. 2011. doi:10.1007/511102-011-0342-z.

    Google Scholar 

  • Chuang CC, Chang CN, Wei KC, Liao CC, Hsu PW, Huang YC, Chen YL, Lai LJ, Pai PC. Surgical treatment for severe visual compromised patients after pituitary apoplexy. J Neurooncol. 2006;80:39–47.

    Article  PubMed  Google Scholar 

  • da Motta LA, de Mello PA, de Lacerda CM, Neto AP, da Motta LD, Filho MF. Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. J Neurosurg Sci. 1999;43:25–36.

    PubMed  Google Scholar 

  • Diederich S, Franzen NF, Bähr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003;148:609–17.

    Article  PubMed  CAS  Google Scholar 

  • Dubuisson A, Beckers A, Stevenaert A. Classical pituitary tumor apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg. 2007;109:63–70.

    Article  PubMed  Google Scholar 

  • Dunn P, Donald R, Espiner E. Regression of acromegaly following pituitary apoplexy. Aust N Z J Med. 1975;5:369–72.

    Article  PubMed  CAS  Google Scholar 

  • Fraser LA, Lee D, Cooper P, Van Uum S. Remission of acromegaly after pituitary apoplexy: case report and review of literature. Endocr Pract. 2009;15:725–31.

    Article  PubMed  Google Scholar 

  • Grant P, Whitelaw B, Barazi S, Aylwin S. Salt and water balance following pituitary surgery. Eur J Endocrinol. 2012. doi:10.1530/EJE-11-0892.

    PubMed  Google Scholar 

  • Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P. Pituitary apoplexy: retrospective review of 30 patients– is surgical intervention always necessary? Br J Neurosurg. 2006;20:379–85.

    Article  PubMed  CAS  Google Scholar 

  • Hout WM, Arafah BM, Salazar R, Selman W. Evaluation of the hypothalamic-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary? J Clin Endocrinol Metab. 1988;66:1208–12.

    Article  PubMed  CAS  Google Scholar 

  • Kamiya Y, Jin-No Y, Tomita K, Suzuki T, Ban K, Sugiyama N, Mase M, Sakuma N, Kimura G. Recurrence of Cushing’s disease after long-term remission due to pituitary apoplexy. Endocr J. 2000;47:793–7.

    Article  PubMed  CAS  Google Scholar 

  • Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K, Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metanalysis. J Clin Endocrinol Metab. 2008;93:4245–53.

    Article  PubMed  CAS  Google Scholar 

  • Kelly D, Laws Jr E, Fossett D. Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases. J Neurosurg. 1995;83:363–7.

    Article  PubMed  CAS  Google Scholar 

  • Kerr JM, Wierman ME. Pituitary apoplexy. BMJ. 2011;342:d1270.

    Article  PubMed  Google Scholar 

  • Kristof R, Rother M, Neuloh G. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg. 2009;111:555–62.

    Article  PubMed  Google Scholar 

  • Laws E. Pituitary tumor apoplexy: a review. J Intensive Care Med. 2008;23:146–7.

    Article  PubMed  Google Scholar 

  • Lee JI, Cho WH, Choi BK, Cha SH, Song GS, Choi CH. Delayed hyponatremia following transsphenoidal surgery for pituitary adenoma. Neurol Med Chir. 2008;48:489–94.

    Article  CAS  Google Scholar 

  • Leyer C, Castinetti F, Morange I, Gueydan M, Oliver C, Conte-Devolx B, Dufour H, Brue T. A conservative management is preferable in milder forms of pituitary tumor apoplexy. J Endocrinol Invest. 2011;34:502–9.

    PubMed  CAS  Google Scholar 

  • Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I. Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien). 2005;147:151–7.

    Article  CAS  Google Scholar 

  • Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995;80:2190–7.

    Article  PubMed  CAS  Google Scholar 

  • Marouf R, Mohr G, Assimakopoulos P, Glikstein R. Apoplectic adenomas: the outcome of the residual pituitary gland (in French). Neurochirurgie. 2010;56:324–30.

    Article  PubMed  CAS  Google Scholar 

  • Mattke A, Vender J, Anstadt M. Pituitary apoplexy presenting as addisonian crisis. Tex Heart Inst J. 2002;29:193–9.

    PubMed  Google Scholar 

  • Mauerhoff T, Leveque P, Lambert A. Spontaneous pituitary apoplexy with transient panhypopituitarism and diabetes insipidus. Acta Clin Belg. 1991;46:30–6.

    PubMed  CAS  Google Scholar 

  • Mou C, Han T, Zhao H, Wang S, Qu Y. Clinical features and immunohistochemical changes of pituitary apoplexy. J Clin Neurosci. 2009;16:64–8.

    Article  PubMed  CAS  Google Scholar 

  • Murad-Kejbou S, Eggenberger E. Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Opthalmol. 2009;20:456–61.

    Article  Google Scholar 

  • Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med. 2008;23:75–90.

    Article  PubMed  Google Scholar 

  • Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, Markey A, Plant G, Powell M, Sinha S, Wass J. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 2011;74:9–20.

    Article  Google Scholar 

  • Renabir S, Baruah M. Pituitary apoplexy. Indian J Endocrinol Metab. 2011;15:S188–96.

    Article  Google Scholar 

  • Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf). 1999;51:181–8.

    Article  CAS  Google Scholar 

  • Reid R, Quigley M, Yen S. Pituitary apoplexy: a review. Arch Neurol. 1985;42:712–9.

    Article  PubMed  CAS  Google Scholar 

  • Semple PL, Webb MK, de Villiers JC, Laws Jr ER. Pituitary apoplexy. Neurosurgery. 2005;56:65–73.

    PubMed  Google Scholar 

  • Shou X, Wang Y, Li S. Microsurgical treatment for typical pituitary apoplexy with 44 patients, according to two pathological stages. Minim Invasive Neurosurg. 2009;52:207–11.

    Article  PubMed  Google Scholar 

  • Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R, Vaidya B. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary. 2004;7:157–63.

    Article  PubMed  Google Scholar 

  • Sweeney AT, Blake MA, Adelman LS, Habeebulla S, Nachtigall LB, Duff JM, Tully 3rd GL. Pituitary apoplexy precipitating diabetes insipidus. Endocr Pract. 2004;10:135–8.

    Article  PubMed  Google Scholar 

  • Tamasawa N, Kurahashi K, Baba T, Hishita R, Murabayashi S, Kashiwamura H, Takebe K. Spontaneous remission of acromegaly after pituitary apoplexy following head trauma. J Endocrinol Invest. 1988;11:429–32.

    PubMed  CAS  Google Scholar 

  • Taylor S, Tyrrell J, Wison CB. Delayed onset of hyponatremia after transsphenoidal surgery for pituitary adenomas. Neurosurgery. 1995;37:649–53.

    Article  PubMed  CAS  Google Scholar 

  • Turgut M, Ozsunar Y, Basak S, Güney E, Kir E, MeteoÄŸlu I. Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien). 2010;152:749–69.

    Article  Google Scholar 

  • Vanderpump M, Higgens C, Wass J. UK guidelines for the management of pituitary apoplexy a rare but potentially fatal medical emergency. Emerg Med J. 2011;28:550–1.

    Article  PubMed  Google Scholar 

  • Zayour DH, Selman WR, Arafah BM. Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. J Clin Endocrinol Metab. 2004;89:5649–54.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick L. Semple MBChB, FCS(SA), MMed, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Semple, P.L., Ross, I.L. (2014). Endocrinopathies and Other Biochemical Abnormalities in Pituitary Apoplexy. In: Turgut, M., Mahapatra, A., Powell, M., Muthukumar, N. (eds) Pituitary Apoplexy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38508-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38508-7_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38507-0

  • Online ISBN: 978-3-642-38508-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics